Members of the protein arginine methyltransferase family are also aberrantly expressed in prostate cancer cells, e.g., PRMT5, which catalyses histone arginine methylation at histone H4R3, causing epigenetic inactivation of several tumour suppressors and thus promoting prostate cancer cell growth [57]. This evidence concerns the gene PRMT5 and prostate carcinoma.